Ambry

By Justin Petrone
Growing demand for arrays designed to detect tumor copy-number changes is enticing more chip manufacturers to offer tools tailor-made for cancer research.

New Product Watch

Premium

Ambry Genetics last week launched its CancerArray, an exon-focused, 180,000-probe array for comparative genomic hybridization.

Ambry's StemArray is manufactured by Roche NimbleGen and enables researchers studying stem cells to detect genomic abnormalities that would ordinarily be missed by low-resolution karyotyping.

CLG will sell the StemArray products and services to its current customers and other companies and research institutions.

Ambry Genetics is now able to offer all Roche NimbleGen applications, the first of Roche NimbleGen's growing list of service providers to achieve such certification.

Ambry is now certified on all Roche NimbleGen applications, offering services from its lab in California.

Under Ion Torrent's new service provider program, CSP certification means that the organization has been trained and tested by Ion Torrent to produce high quality sequence data.

Ambry Genetics has become the first authorized certified service provider for Ion Torrent's Personal Genome Machine.

The deal will make Ambry the preferred provider of genetic carrier screening for LABS and give LABS' customers access to Ambry's genetic screen for identifying carriers of severe and common childhood diseases.

Under its deal with Ambry, the companies will develop a screening panel to sequence the coding regions of 220 key drug metabolism-linked genes; while in a separate deal Roche has agreed to commercialize an ADME gene screening research panel covering 100 percent of 36 genes that will be available on both the GS FLX and the GS Junior systems.

Pages

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.